Bekris, L.M., H.M. Viernes, F.M. Farin, L.A. Maier, T.J. Kavanagh, and T.K. Takaro. 2006. Chronic beryllium disease and glutathione biosynthesis genes. J. Occup. Environ. Med. 48(6):599-606.

Belinsky, S.A., S.S. Snow, K.J. Nikula, G.L. Finch, C.S. Tellez, and W.A. Palmisano. 2002. Aberrant CpG island methylation of the p16INK4a and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis 23(2):335-339.

Bello, D., T.J. Smith, S.R. Woskie, R.P. Streicher, M.F. Boeniger, C.A. Redlich, and Y. Liu. 2006. An FTIR investigation of isocyanate skin absorption using in vitro guinea pig skin. J. Environ. Monit. 8(5):523-529.

Belman, S. 1969. Beryllium binding of epidermal constituents. J. Occup. Med. 11(4):175-183.

Bencko, V., M. Brezina, B. Benes, and M. Cikrt. 1979. Penetration of beryllium through the placenta and its distribution in the mouse. J. Hyg. Epidemiol. Microbiol. Immunol. 23(4):361-367.

Benson, J.M., A.M. Holmes, E.B. Barr, K.J. Nikula, and T.H. March. 2000. Particle clearance and histopathology in lungs of C3H/HeJ mice administered beryllium/copper alloy by intratracheal instillation. Inhal. Toxicol. 12(8):733-749.

Berlin, J.M., J.S. Taylor, J.E. Sigel, W.F. Bergfeld, and R.A. Dweik. 2003. Beryllium dermatitis. J. Am. Acad. Dermatol. 49(5):939-941.

Bill, J.R., D.G. Mack, M.T. Falta, L.A. Maier, A.K. Sullivan, F.G. Joslin, A.K. Martin, B.M. Freed, B.L. Kotzin, and A.P. Fontenot. 2005. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II β-chain. J. Immunol. 175(10):7029-7037.

Bost, T.W., D.W. Riches, B. Schumacher, P.C. Carré, T.Z. Khan, J.A. Martinez, and L.S. Newman. 1994. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interleukin-6 but not interleukin-1β. Am. J. Respir. Cell Mol. Biol. 10(5):506-513.

Brooks, A.L., W.C. Griffith, N.F. Johnson, G.L. Finch, and R.G. Cuddihy. 1989. The induction of chromosome damage in CHO cells by beryllium and radiation given alone and in combination. Radiat. Res. 120(3):494-507.

Brown, S.C., M.F. Schonbeck, D. McClure, A.E. Barón, W.C. Navidi, T. Byers, and A.J. Ruttenber. 2004. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats plant: A case-control study. Am. J. Epidemiol. 160(2):163-172.

Campbell, R.O. 1961. A study of beryllium exposure at a high explosive assembly test facility. Am. Ind. Hyg. Assoc. 22:385-391.

Carpenter, A.V., W.D. Flanders, E.L. Frome, W.G. Tankersley, and S.A. Fry. 1988. Chemical exposures and central nervous system cancers: A case-control study among workers at two nuclear facilities. Am. J. Ind. Med. 13(3):351-362.

Cholak, J., and D.M. Hubbard. 1948. Spectrographic determination of beryllium in biological material and in air. Anal. Chem. 20(1):73-76.

Cianciara, M.J., A.P. Volkova, N.L. Aizina, and O.G. Alekseeva. 1980. A study of humoral and cellular responsiveness in a population occupationally exposed to beryllium. Int. Arch. Occup. Environ. Health 45(1):87-94.

Clary, J.J., C.R. Hopper, and H.E. Stokinger. 1972. Altered adrenal function as an inducer of latent chronic beryllium disease. Toxicol. Appl. Pharmacol. 23(3):365-375.

Clary, J.J., L.S. Bland, and H.E. Stokinger. 1975. The effect of reproduction and lactation on the onset of latent chronic beryllium disease. Toxicol. Appl. Pharmacol. 33(2):214-221.

Cohen, B.S. 1991. Air sampling. Pp. 211-224 in Beryllium: Biomedical and Environmental Aspects, M.D. Rossman, O.P. Preuss, and M.B. Powers, eds. Baltimore, MD: Williams & Wilkins.

Cohen, B.S., N.H. Harley, C.A. Martinelli, and M. Lippmann. 1983. Sampling artifacts in the breathing zone. Pp. 347-360 in Proceedings of the International Symposium on Aerosols in the Mining and Industrial Work Environment, B.Y.H. Liu and V.A. Marple, eds. Minneapolis, MN: Ann Arbor Press.

Cotes, J.E., J.C. Gilson, C.B. McKerrow, and P.D. Oldham. 1983. A long-term follow-up of workers exposed to beryllium. Br. J. Ind. Med. 40(1):13-21.

Cullen, M.R., J.R. Kominsky, M.D. Rossman, M.G. Cherniack, J.A. Rankin, J.R. Balmes, J.A. Kern, R.P. Daniele, L. Palmer, G.P. Naegel, K. McManus, and R. Cruz. 1987. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am. Rev. Respir. Dis. 135(1):201-208.

Cummings, K.J., D.C. Deubner, G.A. Day, P.K. Henneberger, M.M. Kitt, M.S. Kent, K. Kreiss, and C.R. Schuler. 2007. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitization among new workers. Occup. Environ. Med. 64(2):134-140.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement